Company Advances into Next Phase of Regenerative Aesthetics with Industry Veteran SAN DIEGO,...
Patricia Altavilla Appointed as Chief Executive Officer at Suneva Medical
read more
detail
Mayo Clinic Study Reports 47% Reduction in C.diff Infection Rates Using Pulsed Xenon UV Room Disinfection
SAN ANTONIO, Texas—Clostridioides difficile (C.diff) is a serious and highly contagious intestinal...
Avance Nerve Graft Receives Regenerative Medicine Advanced Therapy (RMAT) Designation
RMAT Designation reinforces clinical significance of RANGER® registry data and acknowledges the...
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg
The first long-lasting, FDA approved micro-insert for up to three years of continuous control in...
EW Healthcare Partners Announces the Appointment of Two Senior Executives
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a...
EUSA Pharma Announces Acquisition of Global Rights to SYLVANT (siltuximab) from Janssen Sciences Ireland UC for $115 Million
Acquisition significantly boosts EUSA Pharma’s presence as a global biopharmaceutical company in...
AxoGen Chairman and CEO Karen Zaderej Named Entrepreneur of the Year 2018 Award Winner in Florida
ALACHUA, Florida—(GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and...
AxoGen, Inc Announces Upsizing and Pricing of Public Offering of Common Stock
ALACHUA, Florida (GLOBE NEWSWIRE)—AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and...
Encore Dermatology, Inc. Announces the Launch of IMPOYZ (clobetasol propionate) Cream, 0.025%, a Newly Formulated High-Potency Topical Corticosteroid
MALVERN, Pennsylvania—Encore Dermatology Inc. announces today the availability of a new topical...
pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company will Rebrand as EyePoint Pharmaceuticals, Inc.
WATERTOWN, Massachusetts(GLOBE NEWSWIRE)—pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a specialty...